Literature DB >> 3614516

Serum antibodies to central nervous system antigens: an analysis of their relation with different human neurologic disorders.

P Huppi, L Bologa, N Herschkowitz.   

Abstract

In a previous paper we have presented a double ligand enzyme linked immunosorbent assay (ELISA) technique suitable for the detection of human antibodies to different brain antigens. In the present study, we have applied this technique to the analysis of 100 neurologically affected patients with regard to both a list of clinical parameters and the presence in their sera of nervous tissue specific antibodies, in an attempt to highlight the meaning of such antibodies in different neurologic disorder. We show that the presence of these antibodies cannot be used for elucidation of pathogenesis or for diagnostic purposes, but can be used as a prognostic index.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3614516     DOI: 10.1007/bf00971016

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

Review 1.  Oligodendrocytes, key cells in myelination and target in demyelinating diseases.

Authors:  L Bologa
Journal:  J Neurosci Res       Date:  1985       Impact factor: 4.164

2.  Serum antibodies against central nervous system proteins in human demyelinating disease.

Authors:  J Newcombe; S Gahan; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

3.  Cultured rat spinal cord neurons: interaction with motor neuron disease immunoglobulins.

Authors:  J Digby; R Harrison; A Jehanli; G G Lunt; F Clifford-Rose
Journal:  Muscle Nerve       Date:  1985-09       Impact factor: 3.217

4.  Purification and immunohistochemical localization of rat brain myelin proteolipid protein.

Authors:  H C Agrawal; B K Hartman; W T Shearer; S Kalmbach; F L Margolis
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

5.  Antibodies against oligodendrocytes in serum and CSF in multiple sclerosis and other neurological diseases: 125I-protein A studies.

Authors:  A J Steck; H Link
Journal:  Acta Neurol Scand       Date:  1984-08       Impact factor: 3.209

6.  Isolation and characterization of the nervous system-specific protein 14-3-2 from rat brain. Purification, subunit composition, and comparison to the beef brain protein.

Authors:  P J Marangos; C Zomzely-Neurath; D C Luk; C York
Journal:  J Biol Chem       Date:  1975-03-10       Impact factor: 5.157

7.  Myelin-associated glycoprotein demonstrated immunocytochemically in myelin and myelin-forming cells of developing rat.

Authors:  N H Sternberger; R H Quarles; Y Itoyama; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Myelin basic protein demonstrated immunocytochemically in oligodendroglia prior to myelin sheath formation.

Authors:  N H Sternberger; Y Itoyama; M W Kies; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture.

Authors:  M C Raff; K L Fields; S I Hakomori; R Mirsky; R M Pruss; J Winter
Journal:  Brain Res       Date:  1979-10-05       Impact factor: 3.252

10.  Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals.

Authors:  K Stefansson; L S Marton; M E Dieperink; G K Molnar; W W Schlaepfer; C M Helgason
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

View more
  2 in total

Review 1.  The role of axonal cytoskeleton in diabetic neuropathy.

Authors:  W G McLean
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

Review 2.  Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics.

Authors:  Justin Lengfeld; Hongtao Zhang; Steven Stoesz; Ramachandran Murali; Franklin Pass; Mark I Greene; Peeyush N Goel; Payal Grover
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.